|
|
|
| Effect comparison of the two treatment methods for the type II or III of cesarean scar pregnancy of patients |
| People's Hospital of Pudong New Area, Shanghai, 201299 |
|
|
|
|
Abstract To explore the clinical effect of transvaginal pregnant lesion resection (TPLR) or uterine artery embolization (UAE) combined with curettage for treating patients with type II or type III of cesarean scar pregnancy (CSP). Methods: 77 patients with type II or III CSP were selected and were randomly divided into two groups from March 2017 to January 2023. 36 patients in the observation group were treated with TPLR, and 41 patients in the control group were treated with UAE combined with curettage. The treatment success rate, the hospital expenses, the time of hospital stay, the time of human chorionic gonadotropin (hCG) value returned to the normal range, the total amount of bleeding during the operation, the time of the first menstrual cycle recovery after the operation, the incidence of complications，and the pain score after the operation of the patients were compared between the two groups. Results: There were no significant differences in the treatment success rate (100.0% vs. 97.6%), the intraoperative blood loss (24.4±13.9ml vs. 22.4±8.6ml), and the time of hospital stay (7.3±1.7d vs. 7.0±2.1d) of the patients between the two groups (P>0.05). The hospitalization cost (10808.3±2310.7 yuan), the time of serum hCG level turn to normal range (16.0±3.6d), the menstrual recovery time (30.3±2.1d), the complication rate (0), and the postoperative pain score (4.72±1.67 points) of the patients in the observation group were all significantly lower than those (16888.7±4004.5 yuan, 18.4±3.0d, 32.8±4.6d, 9.8%, and 7.89±1.41 min) of the patients in the control group (all P<0.05). Conclusion: TPLR and UAE combined with curettage for treating the patients with type II or type III CSP have the same therapeutic effectiveness, but TPLR has better recovery and fewer complications after operation.
|
|
|
|
|
|
|
|
|
